Prior reports suggesting HACE1-mediated RAC1 ubiquitination repressed the proliferation of breast and lung cancer cells further corroborate the notion that HACE1 suppresses ESCA progression through RAC1 ubiquitination 39-40. Here, RAC1 is linked to lung carcinoma.